Original Research ArticleIn this prospective randomized control study, we compared the clinical efficacy and safety of equal doses (15 mg) of 0.5% Hyperbaric Ropivacaine with 0.5 % Hyperbaric Bupivacaine for lower torso surgeries under Spinal Anaeasthesia. After Ethical Committee clearance and obtaining informed written consent from the patient, 80 patients of ASA 1 and 2 of age group 25-50 years posted for lower torso surgeries in Government. Mohan Kumaramangalam Medical College were included. Study population was divided into 2 groups-GROUP B(Patients in this group received intrathecal 15 mg (3 ml) of 0.5% Hyperbaric Bupivacaine) GROUP R(Patients in this group received intrathecal 15 mg (3 ml) of 0.5% Hyperbaric Ropivacaine which is prepared aseptically immediately before injection by adding 1 ml (250 mg) of autoclaved 25% dextrose ampoule (10 ml) to 2 ml of commercially available sterile preservative free isobaric solution of 0.75% Ropivacaine).From our study we conclude that the duration of sensory block and motor block in patients receiving 0.5 % hyperbaric Ropivacaine was less when compared to the patients receiving 0.5 % hyperbaric bupivacaine
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.